Clinical Trial Update: Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Envofolimab and Lenvatinib with Gemcitabine plus Cisplatin as first-line therapy for advanced biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Envofolimab
• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: UNKNOWN